17 July 2025
17 July 2025
The transaction between Thermo Fisher and Sanofi is scheduled for completion in Q2 2025, subject to standard closing conditions.
With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.
The restoration of funding arrives as the International AIDS Society’s annual meeting takes place in Rwanda.
FDA reviewers have identified high rates of ocular toxicity as GSK looks to place its blood cancer drug back on the market.
The acquired product assets from dne pharma include Ventizolve, Levopidon and Metadon Dne.
The developments are directed towards providing improved treatment options for individuals with Alzheimer’s disease.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
